Literature DB >> 10678900

Differential bacterial survival, replication, and apoptosis-inducing ability of Salmonella serovars within human and murine macrophages.

W R Schwan1, X Z Huang, L Hu, D J Kopecko.   

Abstract

Salmonella serovars are associated with human diseases that range from mild gastroenteritis to host-disseminated enteric fever. Human infections by Salmonella enterica serovar Typhi can lead to typhoid fever, but this serovar does not typically cause disease in mice or other animals. In contrast, S. enterica serovar Typhimurium and S. enterica serovar Enteritidis, which are usually linked to localized gastroenteritis in humans and some animal species, elicit a systemic infection in mice. To better understand these observations, multiple strains of each of several chosen serovars of Salmonella were tested for the ability in the nonopsonized state to enter, survive, and replicate within human macrophage cells (U937 and elutriated primary cells) compared with murine macrophage cells (J774A.1 and primary peritoneal cells); in addition, death of the infected macrophages was monitored. The serovar Typhimurium strains all demonstrated enhanced survival within J774A.1 cells and murine peritoneal macrophages, compared with the significant, almost 100-fold declines in viable counts noted for serovar Typhi strains. Viable counts for serovar Enteritidis either matched the level of serovar Typhi (J774A. 1 macrophages) or were comparable to counts for serovar Typhimurium (murine peritoneal macrophages). Apoptosis was significantly higher in J774A.1 cells infected with serovar Typhimurium strain LT2 compared to serovar Typhi strain Ty2. On the other hand, serovar Typhi survived at a level up to 100-fold higher in elutriated human macrophages and 2- to 3-fold higher in U937 cells compared to the serovar Typhimurium and Enteritidis strains tested. Despite the differential multiplication of serovar Typhi during infection of U937 cells, serovar Typhi caused significantly less apoptosis than infections with serovar Typhimurium. These observations indicate variability in intramacrophage survival and host cytotoxicity among the various serovars and are the first to show differences in the apoptotic response of distinct Salmonella serovars residing in human macrophage cells. These studies suggest that nonopsonized serovar Typhimurium enters, multiplies within, and causes considerable, acute death of macrophages, leading to a highly virulent infection in mice (resulting in death within 14 days). In striking contrast, nonopsonized serovar Typhi survives silently and chronically within human macrophages, causing little cell death, which allows for intrahost dissemination and typhoid fever (low host mortality). The type of disease associated with any particular serovar of Salmonella is linked to the ability of that serovar both to persist within and to elicit damage in a specific host's macrophage cells.

Entities:  

Mesh:

Year:  2000        PMID: 10678900      PMCID: PMC97241          DOI: 10.1128/IAI.68.3.1005-1013.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Regulation of transcription of katE and katF in Escherichia coli.

Authors:  M R Mulvey; J Switala; A Borys; P C Loewen
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

2.  Spacious phagosome formation within mouse macrophages correlates with Salmonella serotype pathogenicity and host susceptibility.

Authors:  C M Alpuche-Aranda; E P Berthiaume; B Mock; J A Swanson; S I Miller
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

3.  Host restriction phenotypes of Salmonella typhi and Salmonella gallinarum.

Authors:  L Pascopella; B Raupach; N Ghori; D Monack; S Falkow; P L Small
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

4.  In vitro characterization of Salmonella typhi mutant strains for live oral vaccines.

Authors:  E M Dragunsky; E Rivera; H D Hochstein; I S Levenbook
Journal:  Vaccine       Date:  1990-06       Impact factor: 3.641

5.  Phosphatidylinositol-specific phospholipase C from Listeria monocytogenes contributes to intracellular survival and growth of Listeria innocua.

Authors:  W R Schwan; A Demuth; M Kuhn; W Goebel
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

6.  Transepithelial signaling to neutrophils by salmonellae: a novel virulence mechanism for gastroenteritis.

Authors:  B A McCormick; S I Miller; D Carnes; J L Madara
Journal:  Infect Immun       Date:  1995-06       Impact factor: 3.441

7.  Salmonella typhimurium invasion induces apoptosis in infected macrophages.

Authors:  D M Monack; B Raupach; A E Hromockyj; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

8.  Intracellular survival of wild-type Salmonella typhimurium and macrophage-sensitive mutants in diverse populations of macrophages.

Authors:  N A Buchmeier; F Heffron
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

9.  Salmonella stimulate macrophage macropinocytosis and persist within spacious phagosomes.

Authors:  C M Alpuche-Aranda; E L Racoosin; J A Swanson; S I Miller
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

10.  Salmonella typhimurium initiates murine infection by penetrating and destroying the specialized epithelial M cells of the Peyer's patches.

Authors:  B D Jones; N Ghori; S Falkow
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  49 in total

Review 1.  The role of microorganisms in biliary tract disease.

Authors:  Asa Ljungh; Torkel Wadström
Journal:  Curr Gastroenterol Rep       Date:  2002-04

2.  Host adaptation of pigeon isolates of Salmonella enterica subsp. enterica serovar Typhimurium variant Copenhagen phage type 99 is associated with enhanced macrophage cytotoxicity.

Authors:  Frank Pasmans; Filip Van Immerseel; Marc Heyndrickx; An Martel; Claudine Godard; Christa Wildemauwe; Richard Ducatelle; Freddy Haesebrouck
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

3.  Host microarray analysis reveals a role for the Salmonella response regulator phoP in human macrophage cell death.

Authors:  C S Detweiler; D B Cunanan; S Falkow
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

Review 4.  Whipple's disease: a macrophage disease.

Authors:  Benoît Desnues; Melanie Ihrig; Didier Raoult; Jean-Louis Mege
Journal:  Clin Vaccine Immunol       Date:  2006-02

Review 5.  Host specificity of bacterial pathogens.

Authors:  Andreas Bäumler; Ferric C Fang
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

6.  A Salmonella enterica serovar Typhi plasmid induces rapid and massive apoptosis in infected macrophages.

Authors:  Shuyan Wu; Yuanyuan Li; Yang Xu; Qiong Li; Yuanyuan Chu; Rui Huang; Zhenghong Qin
Journal:  Cell Mol Immunol       Date:  2010-05-17       Impact factor: 11.530

Review 7.  A novel anti-microbial function for a familiar Rab GTPase.

Authors:  Stefania Spanò; Jorge E Galán
Journal:  Small GTPases       Date:  2013-12-09

8.  Host adaptation of a bacterial toxin from the human pathogen Salmonella Typhi.

Authors:  Lingquan Deng; Jeongmin Song; Xiang Gao; Jiawei Wang; Hai Yu; Xi Chen; Nissi Varki; Yuko Naito-Matsui; Jorge E Galán; Ajit Varki
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

9.  Characterization of a novel intracellularly activated gene from Salmonella enterica serovar typhi.

Authors:  Holger Basso; Faiza Rharbaoui; Lothar H Staendner; Eva Medina; Francisco García-Del Portillo; Carlos A Guzmán
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Live recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigen.

Authors:  Huoying Shi; Javier Santander; Karen E Brenneman; Soo-Young Wanda; Shifeng Wang; Patti Senechal; Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  PLoS One       Date:  2010-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.